PeptideStack
5.2kquestions
20kanswers
220users

What does a date of analysis on a CPC report change about how I read it?

Asked 27 Jan 2025Modified 14 months agoViewed 29k times
21

For reference: date of analysis · CPC.

I want to understand what this actually establishes, as opposed to what it is being used to imply.

My concern is that I am being invited to draw a conclusion the data does not support.

What is the correct interpretation, and what is the common misreading?

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

436 questions
shareeditfollowflag
RI
askedrukhsana_iqbal14k2827 Jan 2025
2Is there a reason to prefer the second method over the first, other than cost? – Dr_Colm_Fitzhenry 8 months ago
add a comment

5 Answers

Accepted answer first, then by votes
147

Accepted answer

A useful certificate has five elements: the lot number, the analytical method, the reported result with units, the date of analysis, and the primary data or a reference to it.

Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.

Reconciling gross mass to label claim

ComponentTypical shareCounted in purity?Counted in content?
Target peptide88–94 %Yes, as main peakYes
Related impurities1–3 %Yes, as other peaksNo
Counter-ion (TFA or acetate)2–8 %NoNo
Residual water2–6 %NoNo
Bulking agent, if present0–40 %NoNo

To be exact about it, writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.

Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.

Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
DA
answered · acceptedDr_Yusuf_Adeyemi95k24816 Feb 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
59

The relevant detail is that ask whether the certificate answers the question you are actually asking, because the answer is often no.

Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.

A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.

The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.

My working rule is that a document without a lot number, a method section and a test date is marketing.

shareimprove this answerflag
DB
answeredDr_Aoife_Brennan50k485 Feb 2025
42

Put another way, what a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.

The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.

Stated carefully, comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.

Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.

One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.

If the certificate does not trace to your vial, it is not evidence about your vial.

shareimprove this answerflag
SC
answeredstopper_core50k13825 May 2025
3Minor: the trial name is hyphenated in the original publication. – loss_on_drying 9 months ago
add a comment
35

In practice, most certificates are written to look impressive rather than to be informative, and it is worth being sceptical of that gap.

The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.

Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
LD
answeredloss_on_drying47k13814 May 2025
2Have you seen anything published on this, or is it inference from the mechanism? – plate_count_9k 8 months ago
Useful. I have added the accept threshold suggestion to my own notes. – p_mkhize 7 months ago
add a comment
28

Specifically, before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.

The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.

Industry guidance on this topic is consistent because it comes from first principles rather than convention.

My working rule is that a document without a lot number, a method section and a test date is marketing.

shareimprove this answerflag
EV
answeredesther_vandeVelde49k382 Apr 2025
5Note that the label instructions differ between agents on precisely this point. – Dr_Ingrid_Baumgartner 7 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.